Early Predictors of Necrotizing Enterocolitis in Neonates

Running, not enrolling

Conditions studied: Necrotizing Enterocolitis

In brief

The goal of this project is to identify neonates who are predisposed to Necrotizing Enterocolitis (NEC). the investigators will determine the effectiveness of non-invasive measures as well as biochemical markers to identify neonates early in the disease process. Thus, the investigators aim to identify infants with NEC prior to the onset of symptoms to institute or test treatments in the long term to prevent the progression of the disease in these infants.

Key facts

Study ID

NCT03210831

Run by

Nationwide Children's Hospital

People needed

450

Starts

2017-09-06

Expected to finish

2026-12-01

Last updated by the study team

2026-06-08

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Infants born at ≤30 weeks gestational age and/or
• Infants with a birth weight ≤1500 grams

You may not qualify if…

• gestational age at birth greater than 30 weeks
• obvious dysmorphic syndromes
• any abdominal wall defect including omphalocele or gastroschisis
• any known intestinal atresia
• complex cardiac abnormalities
• any known lethal chromosomal abnormalities

Where it is running

• Nationwide Children's Hospital — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.